Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GMAB · against 596 other Healthcare companies listed in US-listed
Ranked #395 of 597 · scores higher than 34% of peers · safety percentile 25
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)59 peers with a safety percentile of 20–29, including GMAB · Click a bar to see the companies
Mainly because of its debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | GMAB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 523 reported | 0.89× | 0.23× | 23% | 33% | |
| BetaLower is better · 556 reported | 0.70 | 0.95 | 64% | 33% | |
| Current ratioHigher is better · 600 reported | 2.46× | 3.91× | 35% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 391 | 28.7B USD | 26 | 52 | |
| 392 | 399M USD | 26 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 32 |
| 393 | 50.2B USD | 25 | 49 |
| 394 | 1.7B USD | 25 | 44 |
| 395 | 34.6B USD | 25 | 58 |
| 396 | 2.0B USD | 25 | 26 |
| 397 | 10.7B USD | 25 | 65 |
| 398 | 363.0B USD | 25 | 47 |
| 399 | 49.5B USD | 24 | 53 |